WINDSOR, ONTARIO--(Marketwire - Feb. 3, 2012) - Essex Angel Capital Inc. (TSX VENTURE:EXC) (the "Corporation" or "Essex") is pleased to announce that Denis Callewaert, Founder and Chief Science Officer of Wellness Indicators, Inc. ("Wellness Indicators"), one of the companies in the Essex portfolio, will be a guest speaker at the National Labor Management Conference in Hollywood, FL, February 16-21, 2012. Dr. Callewaert, who holds a Ph.D. in biochemistry, will be addressing the attendees about the unique aspects of Wellness Indicators' new wellness screening test, the Health Equater™ Assessment Profile.
One thousand attendees at the National Labor Management Conference will be offered the opportunity to participate in field trials of the Health Equater Assessment Profile, which is a quick and inexpensive urine test that screens for biomarkers indicating levels of wellness. The National Labor Management Conference is only one of the sites where the Health Equater Assessment Profile will be field-tested. Further field trials during the first quarter of 2012 will take place at a number of large insurance companies, large employers and organized labor unions. Wellness Indicators has field trial commitment letters from eight organizations, representing over 1,000,000 potential users, of whom 2,000 will be participating in field trials in the first quarter of 2012.
"Wellness Indicators is a game-changer in the Labor space," said Ed Hanley, former Chief Legal Counsel of Hotel Employees and Restaurant Employees and Bartenders International Union and current CEO of A&E Group Health Solutions LLC, "which brings a non-invasive, portable, affordable method for funds and their members to manage their own personal health. I am excited to share this new solution next week at the National Labor Conference, where some 1,000 different funds will be represented."
An international expert in biochemistry and immunology, with a focus on biomarkers for oxidative stress and inflammation, Dr. Callewaert has founded four biotechnology companies, including Wellness Indicators. The company plans to introduce the Health Equater Assessment Profile commercially, after field tests are completed.
The Health Equater Assessment Profile is a first-to-market test screening for such biomarkers as oxidative stress, low-grade inflammation and total antioxidant capacity, which indicate levels of wellness. Thousands of studies have shown that the biomarkers detected by the assessment profile are leading indicators for a variety of future health risks, including stroke, cancer, heart disease, and diabetes.